Effectiveness of Bebtelovimab Against Hospitalization and Death From the Omicron BA.4/BA.5 and BQ.1/BQ.1.1 Subvariants
Abstract
No abstract availableFunding Information
- National Institutes of Health (R01 AI029168, R01 HL149683)
This publication has 3 references indexed in Scilit:
- Impact of Vaccination, Prior Infection, and Therapy on Omicron Infection and MortalityThe Journal of Infectious Diseases, 2022
- Comparable Outcomes for Bebtelovimab and Ritonavir-Boosted Nirmatrelvir Treatment in High-Risk Patients With Coronavirus Disease-2019 During Severe Acute Respiratory Syndrome Coronavirus 2 BA.2 Omicron EpochThe Journal of Infectious Diseases, 2022
- Phenotypes and Subphenotypes of Patients With COVID-19Chest, 2021